임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중단 (진행 중)· B-cell Acute Lymphoblastic LeukemiaA Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
협력: 암젠
- 1상모집 중단 (진행 중)· Healthy ParticipantsComparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
리드: 암젠
- 1/2상모집 중단 (진행 중)· Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 1상모집 중단 (진행 중)· OverweightEffect of Maridebart Cafraglutide on the Heart's Electrical Activity
리드: 암젠
- 1상모집 중단 (진행 중)· Type 2 Diabetes MellitusA Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
리드: 암젠
- 3상모집 중단 (진행 중)· Obesity DiseaseEfficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
리드: 암젠
- 4상모집 중단 (진행 중)· Glucocorticoid-induced OsteoporosisA Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
리드: 암젠
- 3상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM), Obesity, OverweightEfficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
리드: 암젠
- 2상모집 중단 (진행 중)· Metastatic Gastro-esophageal AdenocarcinomaBemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
협력: 암젠
- 2상모집 중단 (진행 중)· Soft Tissue SarcomaNeoadjuvant Intralesional Injection of Talimogene Laherparepvec
협력: 암젠
- 2상모집 중단 (진행 중)· Small Cell Lung Cancer (SCLC)A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
리드: 암젠
- 3상모집 중단 (진행 중)· Relapsing-remitting Multiple Sclerosis (RRMS)Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
리드: 암젠
- 2상모집 중단 (진행 중)· MTAP-deleted NSCLCA Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
리드: 암젠
- 3상모집 중단 (진행 중)· Metastatic Castration-resistant Prostate CancerPhase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
리드: 암젠
- 2상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM)A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
리드: 암젠
- 1상모집 중단 (진행 중)· Prostate CancerEvaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
리드: 암젠
- 3상모집 중단 (진행 중)· Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
리드: 암젠
- 3상모집 중단 (진행 중)· Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerA Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
리드: 암젠
- 2상모집 중단 (진행 중)· Extensive Stage Small Cell Lung CancerStudy Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment
리드: 암젠
- 4상모집 중단 (진행 중)· OsteoporosisEvaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
리드: 암젠
- 2상모집 중단 (진행 중)· B Precursor Acute Lymphoblastic LeukemiaStudy of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
리드: 암젠
- 3상모집 중단 (진행 중)· Prurigo NodularisA Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis
리드: 암젠
- 3상모집 중단 (진행 중)· Extensive-Stage Small-Cell Lung CancerStudy Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
리드: 암젠
- 1상모집 중단 (진행 중)· Advanced Gastrointestinal, Biliary Tract, and Pancreatic CancersA Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
리드: 암젠
- 3상모집 중단 (진행 중)· Osteogenesis ImperfectaStudy to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
리드: 암젠
- 3상모집 중단 (진행 중)· Sjögren's Syndrome (SS)A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
리드: 암젠
- 4상모집 중단 (진행 중)· Neuromyelitis Optica Spectrum DisorderLong-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
리드: 암젠
- 1상모집 중단 (진행 중)· Advanced Solid TumorsA Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
리드: 암젠
- 3상모집 중단 (진행 중)· Limited Stage Small Cell Lung CancerStudy Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
리드: 암젠
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
리드: 암젠
- 4상모집 중단 (진행 중)· Giant Cell Tumor of BoneStudy of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
리드: 암젠
- 단계 미표기모집 중단 (진행 중)· Heart Failure NYHA Class IIEarly Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
협력: 암젠
- 3상모집 중단 (진행 중)· Small Cell Lung Cancer (SCLC)Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
리드: 암젠
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
리드: 암젠
- 3상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
리드: 암젠
- 3상모집 중단 (진행 중)· Eosinophilic EsophagitisEfficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
리드: 아스트라제네카 · 협력: 암젠
- 4상모집 중단 (진행 중)· Cardiovascular DiseaseEVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
리드: 암젠
- 1상모집 중단 (진행 중)· Extensive Stage Small Cell Lung CancerFirst-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
리드: 암젠
- 1/2상모집 중단 (진행 중)· Non Small Cell Lung CancerPhase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients
협력: 암젠
- 1/2상모집 중단 (진행 중)· Advanced MTAP-null Solid TumorsA Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
리드: 암젠
- 단계 미표기모집 중단 (진행 중)· Heart FailureWeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise
협력: 암젠
- 2상모집 중단 (진행 중)· Relapsed/Refractory Small Cell Lung CancerA Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
리드: 암젠
- 3상모집 중단 (진행 중)· Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
리드: 암젠
- 4상모집 중단 (진행 중)· STEMI - ST Elevation Myocardial InfarctionEvolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
협력: 암젠
- 2상모집 중단 (진행 중)· Waldenstrom MacroglobulinemiaEfficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia
협력: 암젠
- 1/2상모집 중단 (진행 중)· Multiple MyelomaStudy of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
협력: 암젠, GSK
- 2상모집 중단 (진행 중)· Premenopausal Idiopathic OsteoporosisRomosozumab/Denosumab Study for Premenopausal IOP
협력: 암젠
- 1/2상모집 중단 (진행 중)· B Cell Precursor Acute Lymphoblastic LeukemiaA Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
리드: 암젠
- 2상모집 중단 (진행 중)· Colorectal CancerPAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence
협력: 암젠
- 3상모집 중단 (진행 중)· IgG4 Related DiseaseA Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.